DNMT3B and immunodeficiency-centromeric instability-facial anomalies syndrome 1: Our work in cells derived from ICF1 patients is compatible with this view since we showed that DNMT3B mutations alter the transcriptional regulation at intragenic level, impairing the proper TSS usage and causing spurious transcription from intragenic cryptic TSS.